Literature DB >> 8294931

Alpha, beta I, beta II, delta, and epsilon protein kinase C isoforms and compound activity in the sciatic nerve of normal and diabetic rats.

I Borghini1, A Ania-Lahuerta, R Regazzi, G Ferrari, A Gjinovci, C B Wollheim, W F Pralong.   

Abstract

Defective protein kinase C (PKC) has been implicated in impaired Na+,K(+)-ATPase activity in the sciatic nerve of streptozotocin-induced diabetic rats. In the present study, alpha, beta I, beta II, gamma, delta, and epsilon isoform-specific antibodies were used in parallel to the measurement of compound PKC activity for the characterization of PKC distribution and isoform expression in sciatic nerves of normal and diabetic rats. To distinguish isoform expression between the axonal and glial compartments, PKC isoforms were evaluated in nerves subjected to Wallerian degeneration and in a pure primary Schwann cell culture. alpha, beta I, beta II, delta, and epsilon but no gamma isoforms were detected in sciatic nerve. Similar immunoreactivity was observed in degenerated nerves 3-4 days after transection except for diminished beta I and epsilon species; in Schwann cell cultures, only alpha, beta II, delta, and epsilon were detected. In normal nerves, two-thirds of PKC compound activity was found in the cytosol and 50% of total enzyme activity translocated to the Na+,K(+)-ATPase-enriched membrane fraction with phorbol myristate acetate. Similar redistribution patterns were observed for the immunoreactivity of all isoforms with the exception of delta, which did not translocate to the membrane with phorbol myristate acetate. No abnormality in compound PKC activity, in the immunoreactive intensity, or in the distribution of PKC isoforms could be detected in rat sciatic nerve after 6-12 weeks of diabetes. Thus, defective activation rather than decreased intrinsic PKC activity may occur in diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294931

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 2.  Phosphorylation of myelin protein: recent advances.

Authors:  J Eichberg; S Iyer
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

Review 3.  Activation of protein kinase C isoforms and its impact on diabetic complications.

Authors:  Pedro Geraldes; George L King
Journal:  Circ Res       Date:  2010-04-30       Impact factor: 17.367

Review 4.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 5.  The role of axonal cytoskeleton in diabetic neuropathy.

Authors:  W G McLean
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 6.  Anandamide and vanilloid TRPV1 receptors.

Authors:  Ruth A Ross
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

7.  In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulators.

Authors:  I Borghini; K Geering; A Gjinovci; C B Wollheim; W F Pralong
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

8.  Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.

Authors:  H Shindo; T P Thomas; D D Larkin; A K Karihaloo; H Inada; T Onaya; M J Stevens; D A Greene
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Streptozotocin-induced diabetes elicits the phosphorylation of hepatocyte Gi2 alpha at the protein kinase C site but not at the protein kinase A-controlled site.

Authors:  N J Morris; M Bushfield; M D Houslay
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

10.  Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.

Authors:  Cendrine Cabou; Christelle Vachoux; Gérard Campistron; Daniel J Drucker; Rémy Burcelin
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.